Ficusin is a research compound with demonstrated antidiabetic and anti-obesity properties in preclinical models. Studies in HFD-STZ induced diabetic rats show it reduces fasting glucose, insulin, and body weight by enhancing PPARgamma expression and GLUT4 activity in adipose tissue, indicating improved insulin sensitivity. This makes it a candidate for investigating mechanisms and potential therapies for type 2 diabetes.
Molekulargewicht:
404.46
CAS Nummer:
[173429-83-9]
Formel:
C25H24O5
Target-Kategorie:
transporter,PPAR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten